Home › Funds › PFM Health Sciences, LP › THC
PFM Health Sciences, LP position in THC
TENET HEALTHCARE CORP · Health Care
PFM Health Sciences, LP reported holding 127,294 shares of THC (TENET HEALTHCARE CORP) in its Q3 2026 13F filing — a position valued at US$32.5M, representing 3.32% of its reported portfolio and ranking #5 among its reported holdings. PFM Health Sciences, LP has disclosed THC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How PFM Health Sciences, LP's THC position evolved
PFM Health Sciences, LP first disclosed a stake in THC in Q3 2023 at 578,704 shares (US$38.1M). The position peaked in Q3 2024 at 589,409 shares, worth US$98.0M. Across 13 filings, PFM Health Sciences, LP increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 127,294 shares valued at US$32.5M — an increase of 722 shares quarter over quarter.. Notable position changes include a 68% trim in Q2 2026 (shares rose 37% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 578.70K | $38.13M | New |
| Q4 2023 | 589.41K | $44.54M | Add |
| Q1 2024 | 589.41K | $61.95M | Hold |
| Q2 2024 | 589.41K | $78.41M | Hold |
| Q3 2024 | 589.41K | $97.96M | Hold |
| Q4 2024 | 491.33K | $62.02M | Reduce |
| Q1 2025 | 491.33K | $66.08M | Hold |
| Q2 2025 | 499.24K | $87.87M | Add |
| Q3 2025 | 461.65K | $93.73M | Reduce |
| Q4 2025 | 397.77K | $79.04M | Reduce |
| Q1 2026 | 398.57K | $75.21M | Hold |
| Q2 2026 | 126.57K | $23.68M | Reduce |
| Q3 2026 | 127.29K | $32.53M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About THC and 13F data
THC (TENET HEALTHCARE CORP) is a Health Care company. 35 other funds we track also report a position in THC — the largest reported positions include Boston Partners (US$1.04B), GLENVIEW CAPITAL MANAGEMENT, LLC (US$418.2M), MANNING & NAPIER ADVISORS LLC (US$153.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding THC
- Boston Partners 4.06M sh · $1.04B · Q3 2026
- GLENVIEW CAPITAL MANAGEMENT, LLC 2.24M sh · $418.25M · Q2 2026
- MANNING & NAPIER ADVISORS LLC 562.72K sh · $153.76M · Q3 2026
- EMINENCE CAPITAL, LP 790.30K sh · $149.14M · Q1 2026
More on PFM Health Sciences, LP
FAQ
How long has PFM Health Sciences, LP held THC?
PFM Health Sciences, LP has disclosed THC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is PFM Health Sciences, LP's current position in THC?
As of Q3 2026, PFM Health Sciences, LP holds 127.29K shares of THC (TENET HEALTHCARE CORP), valued at $32.53M, representing 3.32% of its reported portfolio and ranking #5.
Has PFM Health Sciences, LP been buying or selling THC?
In the latest 13F filing (Q3 2026), PFM Health Sciences, LP increased its position in THC. The position peaked in Q3 2024 at 589.41K shares.
Which other funds hold THC?
Other major institutional holders of THC include Boston Partners, GLENVIEW CAPITAL MANAGEMENT, LLC, MANNING & NAPIER ADVISORS LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.